StockDuty ← Dashboard Sep 30, 2026 03:43 AM ET
SignalCorporate

IOVANCE BIOTHERAPEUTICS SURGES AFTER LIFTING 2026 REVENUE OUTLOOK - QUIVER QUANTITATIVE - GNEWS

Iovance Biotherapeutics surges after raising its 2026 revenue outlook.

What changed
Iovance Biotherapeutics surges after raising its 2026 revenue outlook.
Why it matters
Iovance Biotherapeutics surges after raising its 2026 revenue outlook. — impact context not separately stored; see What changed.
Sources
gnews
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →